Gossamer Bio, Inc.
GOSS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728117
No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Gossamer Bio, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 105 | 1 | 119 | +15 |
| Shares | 171.4M | 142.3K | 169.6M | −1.60M (−0.9%) |
| Value | $155.0M | $128.7K | $186.9M | +$32.0M (+20.6%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (24)
Institutions that held Gossamer Bio, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (9)
Institutions that held Gossamer Bio, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Aster Capital Management (DIFC) Ltd | 134,563 | $121.7K |
| Fullcircle Wealth LLC | 47,954 | $62.8K |
| Callan Capital, LLC | 30,000 | $27.1K |
| Cetera Investment Advisers | 25,036 | $22.6K |
| Stephenson National Bank & Trust | 25,000 | $22.6K |
| XTX Topco Ltd | 21,339 | $19.3K |
| Wolverine Trading, LLC | 18,912 | $16.6K |
| R Squared Ltd | 3,360 | $3.04K |
| Farther Finance Advisors, LLC | 400 | $362 |
Not filed for Q1 2025 yet (1)
Institutions that held Gossamer Bio, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Merriman Wealth Management, LLC | 142,269 | $128.7K |